[1]Patent:CN110078668,2019,A.Locationinpatent:Paragraph0054;0057
[2]EuropeanJournalofMedicinalChemistry,2020,vol.186
1004-66-6
16737-71-6
18800-32-3
26583-60-8
71672-75-8
578-58-5
69214-09-1 | 5-Bromoimidazo[1,2-a]pyridine | AA003MHB | MFCD08275698
2818-69-1 | 5-chloro-2-methyl-1H-1,3-benzodiazole | AA003MKJ | MFCD00014559
827-20-3 | 5-Fluoro-2-(trifluoromethyl)aniline | AA003MNP | MFCD06660353
216766-13-1 | 5-Methoxy-2-(trifluoromethyl)pyridine | AA003MR5 | MFCD09864699
618-88-2 | 5-Nitroisophthalic acid | AA003MUL | MFCD00007254
529-84-0 | 4-Methylesculetin | AA003MYC | MFCD00006859
51484-06-1 | 6-Bromo-4-oxo-4H-chromene-2-carboxylic acid | AA003N1V | MFCD01242619
343-10-2 | 6-Fluoro-4-hydroxyquinoline-3-carboxylic acid | AA003N4W | MFCD00973836
885519-61-9 | 6-Nitro-1H-indazole-4-carboxylic acid | AA003N8F | MFCD07781677
837-52-5 | 7-Chloro-4-piperazin-1-yl-quinoline | AA003NBS | MFCD01476123